Cleveland·Miami·Basel·Tel AvivForce Multipliers  ·  Elevate Humanity
Home / Team / Peleg Chevion
Managing Partner

Peleg Chevion

Managing Partner of LeverVenture, covering Europe and Israel, from Basel and Tel Aviv.

§ 01  /  02
Profile

Biography and focus

Portrait of Peleg Chevion, Managing Partner of LeverVenture
Managing Partner · LeverVenture

Three decades of operational leadership across agriculture, pharmaceuticals, biotechnology, climate, food and defense. He has spent that career doing the work this seat requires: strategic partnerships, licensing and business development, executed transaction by transaction. He sits with a company as an operating partner and a growth strategist rather than as a name on its board. A corporate finance and intellectual property attorney, an INSEAD MBA, and a former Air Force officer in aerospace. He also brings strong private equity experience.

Focus
Strategic partnerships, licensing and business development
Role
Operating partner and growth strategist
Coverage
Europe and Israel, from Basel and Tel Aviv
LinkedIn profile
§ 02  /  02
Insights

Published by Peleg Chevion

20 insights on leverventure.com, most recent first.

  1. How Medtech and Surgical Robotics Founders Should Approach Growth CapitalLife Sciences and Healthcare
  2. Funding the Longevity Economy: A Growth Capital Guide for Longevity and Neuro FoundersLife Sciences and Healthcare
  3. Private Equity Meets the Mid-Market: Borrowing PE's Discipline Without the BuyoutGrowth Equity
  4. The Term Sheet Guide for Life Sciences and Healthcare FoundersGrowth Equity
  5. The Finance of Scaling: A Growth-Stage Operator's Guide to the Metrics That Move Enterprise ValueGrowth Equity
  6. When Your Operational Infrastructure Is the Fundraising Story: What Growth-Stage Founders Actually Get Scrutinized OnLife Sciences and Healthcare
  7. Dual-Use Deep Tech: The Defense-Adjacent Growth-Equity Playbook for FoundersGrowth Equity
  8. Best Growth Equity Firms for Life Sciences in 2025: A Founder's Ranking GuideGrowth Equity
  9. Secondary Markets in Growth Equity: 2025 Liquidity RevolutionGrowth Equity
  10. The ROI² Philosophy: Returns and ImpactImpact
  11. Precision Medicine Investment Landscape 2025Life Sciences and Healthcare
  12. Precision Medicine Breakthroughs: Making Personalized Cancer Treatment AccessibleLife Sciences and Healthcare
  13. Middle Market Private Equity: The Overlooked Sweet SpotGrowth Equity
  14. Mental Health Technology: Breaking Down Treatment Access BarriersLife Sciences and Healthcare
  15. Gene Therapy Commercial Viability: From Approval to Patient AccessLife Sciences and Healthcare
  16. FDA Digital Health Guidance: Regulatory Clarity Accelerates InnovationLife Sciences and Healthcare
  17. Democratizing Healthcare Access: Digital Platforms Bridging Rural Care GapsLife Sciences and Healthcare
  18. Cross-Border Investment: Navigating Complexity for ReturnsGrowth Equity
  19. Biotech Funding Environment: Post-IPO Window AnalysisLife Sciences and Healthcare
  20. Industry Case Study: Ather Energy's Electric Mobility RevolutionImpact
Contact

Ask Peleg Chevion a direct question, and get a direct answer back.

About the firm